FindTrial
Sign In

Study of acne scars and research on best treatment modality for depressed acne scars

A Clinical Study of Acne Scars and Split-face comparative study of Fractional CO2 Laser vs Fractional CO2 Lazer with Platelet-rich Plasma Theray in Treatment of Atrophic Acne Scars

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050273
Enrollment
188
Registered
2023-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Fractional CO2 Laser Therapy: Fractional CO2 Laser Therapy will be used for treatment of atrophic acne scars Intervention2: Fractional CO2 Laser therapy along with Platelet rich plasma

Sponsors

Yenepoya Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with acne scar for clinical study Patients with grade 3and 4 acne scars for interventional study

Exclusion criteria

Exclusion criteria: Patients with HIV, HBV, Reccurent HSV. Patients with bleeding manifestations. Patients with keloidal tendencies. Patients with unrealistic expectations and not willing for follow-up

Design outcomes

Primary

MeasureTime frame
We will be able to clinically grade acne scars for the purpose of finding best possible treatment modality for treatment of atrophic acne scarsTimepoint: 1- Baseline—

Secondary

MeasureTime frame
We will be able to compare the efficacy and safety of Fractional CO2 Laser Therapy with Platelet-rich Plasma Therapy versus Fractional CO2 Laser Therapy alone in treatment of atrophic acne scars.Timepoint: 2- 4th week, 3- 8th week and 4- 12th week—

Countries

India

Contacts

Public ContactSebastian Thomas

Rajiv Gandhi University of Health Sciences Bangalore

drvishalamin@gmail.com9880299783

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026